Polyrizon (PLRZ) announced that it has received formal confirmation from the Hearings Advisor of the Office of the General Counsel of the Nasdaq Hearings Panel of The Nasdaq Stock Market that the Company has regained compliance with all applicable listing requirements.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PLRZ:
- Polyrizon Ltd. Announces Special General Meeting for September 2025
- Biotech Alert: Searches spiking for these stocks today
- Polyrizon Achieves Breakthrough in Allergy Blocker Study
- Polyrizon reports successful intranasal delivery of PL-14 Allergy Blocker
- Polyrizon retains Nasdaq listing following hearings panel